Burrill & Company reports a record $65.3 billion has been spent by U.S. Biopharmaceutical Companies on Research ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE